These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31563287)

  • 1. Cannabis policies in Canada: How will we know which is best?
    Shanahan M; Cyrenne P
    Int J Drug Policy; 2021 May; 91():102556. PubMed ID: 31563287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical policies in Canada: another example of federal-provincial discord.
    Anis AH
    CMAJ; 2000 Feb; 162(4):523-6. PubMed ID: 10701389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
    Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
    Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-Stage Cannabis Regulatory Policy Planning Across Canada's Four Largest Provinces: A Descriptive Overview.
    Watson TM; Hyshka E; Bonato S; Rueda S
    Subst Use Misuse; 2019; 54(10):1691-1704. PubMed ID: 31076006
    [No Abstract]   [Full Text] [Related]  

  • 5. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
    Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
    Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost benefit analysis of two policy options for cannabis: status quo and legalisation.
    Shanahan M; Ritter A
    PLoS One; 2014; 9(4):e95569. PubMed ID: 24755942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Zealand's 'Cannabis Legalisation and Regulation Bill': an evidence-based assessment and critique of essential regulatory components towards policy outcomes.
    Fischer B; Daldegan-Bueno D
    N Z Med J; 2020 Jul; 133(1519):103-111. PubMed ID: 32777801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.
    Fischer B; Daldegan-Bueno D; Boden JM
    Drug Alcohol Rev; 2020 Jul; 39(5):555-567. PubMed ID: 32436274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-benefit analysis framework for preventive health interventions to aid decision-making in Australian governments.
    Ananthapavan J; Moodie M; Milat A; Veerman L; Whittaker E; Carter R
    Health Res Policy Syst; 2021 Dec; 19(1):147. PubMed ID: 34923970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada.
    Lake S; Kerr T; Werb D; Haines-Saah R; Fischer B; Thomas G; Walsh Z; Ware MA; Wood E; Milloy MJ
    Drug Alcohol Rev; 2019 Sep; 38(6):606-621. PubMed ID: 31577059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Municipal regulation of cannabis and public health in Canada: A comparison of Alberta, Ontario, and Québec.
    Gagnon F; Huynh C; Kilborn M; Fry M; Vallée R; Janezic I
    Behav Sci Law; 2022 Mar; 40(2):271-291. PubMed ID: 35470465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Devil Is in the Details! On Regulating Cannabis Use in Canada Based on Public Health Criteria Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts".
    Rehm J; Crépault JF; Fischer B
    Int J Health Policy Manag; 2017 Mar; 6(3):173-176. PubMed ID: 28812798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.
    Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P
    Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drug use and harms, and related interventions and policy in Canada: A narrative review of select key indicators and developments since 2000.
    Fischer B; Murphy Y; Rudzinski K; MacPherson D
    Int J Drug Policy; 2016 Jan; 27():23-35. PubMed ID: 26359046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic Differences in Cannabis Conversations on Twitter: Infodemiology Study.
    van Draanen J; Tao H; Gupta S; Liu S
    JMIR Public Health Surveill; 2020 Oct; 6(4):e18540. PubMed ID: 33016888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study.
    Myran DT; Brown CRL; Tanuseputro P
    CMAJ Open; 2019; 7(3):E454-E461. PubMed ID: 31409593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal cannabis market shares during Canada's first year of recreational legalisation.
    Armstrong MJ
    Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review.
    Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T
    Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Le marché légal du cannabis suite à sa légalisation au Canada : pistes de réflexion pour un encadrement efficace.
    Patenaude C; Brochu S; Fallu JS; Jutras-Aswad D; D'Arcy L
    Can J Public Health; 2018 Apr; 109(2):215-218. PubMed ID: 29981041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.